Prices delayed by at least 15 minutes | Print
Glaukos Corp (GKOS)
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
Address
229 Avenida Fabricante
San Clemente
CA
USA
92672
Telephone
+1 949 3679600
Forecast key dates
| Name | Key Date |
|---|---|
| Glaukos Corp First Quarter Earnings Conference Call for 2025 | 2025-05-01T16:30:00 |
| Glaukos Corp First Quarter Earnings Results for 2025 | 2025-05-01T00:00:00 |
| Glaukos Corp Fourth Quarter Earnings Conference Call for 2024 | 2025-02-21T16:30:00 |
| Glaukos Corp Fourth Quarter Earnings Results for 2024 | 2025-02-21T00:00:00 |
| Glaukos Corp Annual Report for 2024 | 2025-02-21T00:00:00 |
| Glaukos Corp Third Quarter Earnings Conference Call for 2024 | 2024-11-01T16:30:00 |
| Glaukos Corp Third Quarter Earnings Results for 2024 | 2024-11-01T00:00:00 |
| Glaukos Corp Second Quarter Earnings Conference Call for 2024 | 2024-08-02T16:30:00 |
| Glaukos Corp Second Quarter Earnings Results for 2024 | 2024-08-02T00:00:00 |
| Glaukos Corp Annual General Meeting for 2024 | 2024-05-31T09:00:00 |
| Glaukos Corp First Quarter Earnings Conference Call for 2024 | 2024-05-01T16:30:00 |
| Glaukos Corp First Quarter Earnings Result for 2024 | 2024-05-01T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Glaukos Corp Annual General Meeting for 2024 | 2024-05-31T09:00:00 |
| Glaukos Corp First Quarter Earnings Conference Call for 2024 | 2024-05-01T16:30:00 |
| Glaukos Corp First Quarter Earnings Result for 2024 | 2024-05-01T00:00:00 |
| Glaukos Corp Annual Report for 2023 | 2024-02-23T00:00:00 |
| Glaukos Corp Fourth Quarter Earnings Conference Call for 2023 | 2024-02-21T16:30:00 |
| Glaukos Corp Fourth Quarter Earnings Result for 2023 | 2024-02-21T00:00:00 |
| Glaukos Corp Third Quarter Earnings Conference Call for 2023 | 2023-11-01T16:30:00 |
| Glaukos Corp Third Quarter Earnings Result for 2023 | 2023-11-01T00:00:00 |
| Glaukos Corp Second Quarter Earnings Conference Call for 2023 | 2023-08-02T16:30:00 |
| Glaukos Corp Second Quarter Earnings Result for 2023 | 2023-08-02T00:00:00 |
| Glaukos Corp Annual General Meeting for 2023 | 2023-06-01T09:00:00 |
| Glaukos Corp First Quarter Earnings Conference Call for 2023 | 2023-05-03T16:30:00 |
| Glaukos Corp First Quarter Earnings Result for 2023 | 2023-05-03T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.